Figure_7.tif (400.21 kB)

Proportion (%) of HCV-infected PWID entering antiviral treatment in observational studies in non-clinical settings.

Download (0 kB)
figure
posted on 28.07.2014 by Lucas Wiessing, Marica Ferri, Bart Grady, Maria Kantzanou, Ida Sperle, Katelyn J. Cullen, Angelos Hatzakis, Maria Prins, Peter Vickerman, Jeffrey V. Lazarus, Vivian D. Hope, Catharina Matheï

Proportion (%) of HCV-infected PWID entering antiviral treatment in observational studies in non-clinical settings.

History

Licence

Exports